The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/IIa study evaluating the safety and clinical activity of osimeritinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients (AUTOMAN).
 
Baohui Han
No Relationships to Disclose
 
Bo Yan
No Relationships to Disclose
 
Aiqin Gu
No Relationships to Disclose
 
Tianqing Chu
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Huiming Wang
No Relationships to Disclose
 
Hua Zhong
No Relationships to Disclose
 
Chunlei Shi
No Relationships to Disclose
 
Xueyan Zhang
No Relationships to Disclose